This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The total ceiling value of the contract is $108,666.14, with a performance period through October 10, 2024. This award is under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, with a ceiling value of $51,614.77 and a performance period through December 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The firm-fixed-price contract has a ceiling value of $7,735.40 and an ultimate completion date of August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The contract has a ceiling value of $66,409.10 and an ultimate completion date of January 5, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The contract has a ceiling value of $48,478.40 and an ultimate completion date of August 24, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026....
This is a firm fixed price delivery order award to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The total ceiling value of the order is $10,128.06 and the period of performance runs through April 1, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of STELARA 90 MG/ML syringes. The contract has a total ceiling value of $24,049.46 and a period of performance through July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which allows DLA to efficiently procure a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $42,929.04 and covers the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract is a Firm Fixed Price arrangement, with an ultimate completion date of August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The order has a ceiling value of $36,125.21 and a performance period ending on August 8, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This delivery order...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The order has a ceiling value of $9,940.72 and a performance period ending on August 19, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...